AVXL
#3713
Anavex Life Sciences Corp. - Common Stock
1.4 8 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.99%
Variación mensual
-42.86%
Variación en los últimos 6 meses
-53.02%
Cambio anual
-83.18%
Cierres anteriores
1.5 1
Open
1.5 3
Mínimo
1.4 8
Máximo
1.5 3
Financials
- Market Capitalization 137.19 M
- Employee 34
- Founded 2004
- CEO Christopher U. Missling Ph.D.
- Website www.anavex.com
- Headquarter New York, United States
- FIGI BBG000C9K8K4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.48
Relación precio/flujo de caja
174.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3697 |  CUE Cue Biopharma, Inc. - Common Stock | 19.57 USD | -20.48% | -14.62% | -36.15% | +2346.25% | 142.16 M USD | ||
| 3711 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.47 USD | -0.68% | -3.92% | -20.54% | -30.66% | 137.77 M USD | ||
| 3717 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -6.67% | -12.50% | +35.76% | 136.33 M USD | ||
| 3719 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 3.60 USD | -16.28% | -28.29% | -33.70% | +197.52% | 135.85 M USD |